MCT Korea

Company Description

MCT Korea Co., Ltd.(MCT) is a bio-venture firm concentrating on research & development, and was incorporated in August 2000 with a great ambition dedicatedd to human health care. Becoming one of the leading global companies through development of pharmaceuticals and bio-technologies Dr. Soon-Ku Moon has been taking the lead in the development of active pharmaceutical ingredients in the past 25 years, and is a globally renowned scientist in bio-technology as MCT Koreall as technology of finished pharmaceutical dosages.

MCT Korea's main objectives of research are the development of chiral drug by chiral technologies and Drug delivery system by using bio-polymer, and manufacturing process of active pharmaceutical ingredients. A successful progress has been attained in the development and marketing of active pharmaceutical ingredients thanks to the innovative developments as follows

- The upgraded technology for Chiral compounds in terms of separation and purification.
- The reformation of active drug substances as single isomer, active metalbolites or in conjunction with new delivery system is intended primarily to achieve improved performance of the drug.

MCT Korea has a confidence in becoming a leading company in the field of pharmaceuticals and bio-technologies both nominally and virtually, based on plentiful business experience and innovative core-technologies with three patented and two ready.